Loading…
PHLPP1 inhibits the growth and aerobic glycolysis activity of human ovarian granular cells through inactivating AKT pathway
Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphologic features, and PCOS is associated with infertility. PH domain Leucine-rich repeat Protein Phosphatase 1 (PHLPP1) has been shown to regulate AKT. The aim of prese...
Saved in:
Published in: | BMC women's health 2024-01, Vol.24 (1), p.25-25, Article 25 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c515t-502650a80ad7448b8490a03ed3d53ebcb55bdaf6756a589137029b1fbccdf29f3 |
container_end_page | 25 |
container_issue | 1 |
container_start_page | 25 |
container_title | BMC women's health |
container_volume | 24 |
creator | Yang, Xiaoyan A, Min Gegen, Tana Daoerji, Badema Zheng, Yue Wang, Aiming |
description | Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphologic features, and PCOS is associated with infertility. PH domain Leucine-rich repeat Protein Phosphatase 1 (PHLPP1) has been shown to regulate AKT. The aim of present study is to investigate the role of PHLPP1 in PCOS.
The expression levels of PHLPP1 in dihydrotestosterone (DHT)-treated human ovarian granular KGN cells were determined by qRT-PCR and Western blot. PHLPP1 was silenced or overexpressed using lentivirus. Cell proliferation was detected by CCK-8. Apoptosis and ROS generation were analyzed by flow cytometry. Glycolysis was analyzed by measuring extracellular acidification rate (ECAR).
DHT treatment suppressed proliferation, promoted apoptosis, enhanced ROS, and inhibited glycolysis in KGN cells. PHLPP1 silencing alleviated the DHT-induced suppression of proliferation and glycolysis, and promotion of apoptosis and ROS in KGN cells. PHLPP1 regulated cell proliferation and glycolysis in human KGN cells via the AKT signaling pathway.
Our results showed that PHLPP1 mediates the proliferation and aerobic glycolysis activity of human ovarian granular cells through regulating AKT signaling. |
doi_str_mv | 10.1186/s12905-023-02872-5 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ddfb52e472bb49668c80cbb317dc533d</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A778492863</galeid><doaj_id>oai_doaj_org_article_ddfb52e472bb49668c80cbb317dc533d</doaj_id><sourcerecordid>A778492863</sourcerecordid><originalsourceid>FETCH-LOGICAL-c515t-502650a80ad7448b8490a03ed3d53ebcb55bdaf6756a589137029b1fbccdf29f3</originalsourceid><addsrcrecordid>eNptkk9vFCEYxidGY2v1C3gwJF68bIUBBuZkNo3axk3cQz2Tlz8zw2Z2WGFmm41fXqZba9cYQiDwvD_g4SmKtwRfEiKrj4mUNeYLXNLcpSgX_FlxTlieVFKw50_mZ8WrlDYYEyG5eFmcUUkk4xU5L36tr1frNUF-6Lz2Y0Jj51Abw93YIRgsAheD9ga1_cGE_pB8QmBGv_fjAYUGddMWBhT2EH0e2wjD1ENExvX9jIpharvMvi-B0Q8tWn67RTsYuzs4vC5eNNAn9-ZhvCh-fPl8e3W9WH3_enO1XC0MJ3xccFxWHIPEYAVjUktWY8DUWWo5ddpozrWFphK8Ai5rQgUua00abYxtyrqhF8XNkWsDbNQu-i3Egwrg1f1CiK2COHrTO2Vto3npsm9as7qqpJHYaE2JsIZTajPr05G1m_TWWeOGMUJ_Aj3dGXyn2rBXBAtBKsEy4cMDIYafk0uj2vo0GwaDC1NSZZ0_l1FRyyx9_490E6Y4ZK9mFSslYzX_q2ohv8APTcgHmxmqlkJkt0pZ0ay6_I8qN-u23oTBNT6vnxSUxwITQ0rRNY-PJFjN-VPH_KmcP3WfPzXf5d1Tex5L_gSO_gY6lda2</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2914284495</pqid></control><display><type>article</type><title>PHLPP1 inhibits the growth and aerobic glycolysis activity of human ovarian granular cells through inactivating AKT pathway</title><source>PubMed Central (Open Access)</source><source>Publicly Available Content Database</source><creator>Yang, Xiaoyan ; A, Min ; Gegen, Tana ; Daoerji, Badema ; Zheng, Yue ; Wang, Aiming</creator><creatorcontrib>Yang, Xiaoyan ; A, Min ; Gegen, Tana ; Daoerji, Badema ; Zheng, Yue ; Wang, Aiming</creatorcontrib><description>Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphologic features, and PCOS is associated with infertility. PH domain Leucine-rich repeat Protein Phosphatase 1 (PHLPP1) has been shown to regulate AKT. The aim of present study is to investigate the role of PHLPP1 in PCOS.
The expression levels of PHLPP1 in dihydrotestosterone (DHT)-treated human ovarian granular KGN cells were determined by qRT-PCR and Western blot. PHLPP1 was silenced or overexpressed using lentivirus. Cell proliferation was detected by CCK-8. Apoptosis and ROS generation were analyzed by flow cytometry. Glycolysis was analyzed by measuring extracellular acidification rate (ECAR).
DHT treatment suppressed proliferation, promoted apoptosis, enhanced ROS, and inhibited glycolysis in KGN cells. PHLPP1 silencing alleviated the DHT-induced suppression of proliferation and glycolysis, and promotion of apoptosis and ROS in KGN cells. PHLPP1 regulated cell proliferation and glycolysis in human KGN cells via the AKT signaling pathway.
Our results showed that PHLPP1 mediates the proliferation and aerobic glycolysis activity of human ovarian granular cells through regulating AKT signaling.</description><identifier>ISSN: 1472-6874</identifier><identifier>EISSN: 1472-6874</identifier><identifier>DOI: 10.1186/s12905-023-02872-5</identifier><identifier>PMID: 38184561</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Acidification ; AKT signaling ; Analysis ; Apoptosis ; Care and treatment ; Cell growth ; Diagnosis ; Enzymes ; Female ; Glucose metabolism ; Glycolysis ; Health aspects ; Hormones, Sex ; Humans ; Infertility ; Kinases ; Measurement ; Metabolism ; Motility ; Nuclear Proteins ; Ovaries ; PHLPP1 ; Phosphatases ; Phosphoprotein Phosphatases - genetics ; Polycystic Ovary Syndrome ; Proteins ; Proto-Oncogene Proteins c-akt ; Reactive Oxygen Species ; Sperm ; Stein-Leventhal syndrome</subject><ispartof>BMC women's health, 2024-01, Vol.24 (1), p.25-25, Article 25</ispartof><rights>2024. The Author(s).</rights><rights>COPYRIGHT 2024 BioMed Central Ltd.</rights><rights>2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c515t-502650a80ad7448b8490a03ed3d53ebcb55bdaf6756a589137029b1fbccdf29f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10771674/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2914284495?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38184561$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yang, Xiaoyan</creatorcontrib><creatorcontrib>A, Min</creatorcontrib><creatorcontrib>Gegen, Tana</creatorcontrib><creatorcontrib>Daoerji, Badema</creatorcontrib><creatorcontrib>Zheng, Yue</creatorcontrib><creatorcontrib>Wang, Aiming</creatorcontrib><title>PHLPP1 inhibits the growth and aerobic glycolysis activity of human ovarian granular cells through inactivating AKT pathway</title><title>BMC women's health</title><addtitle>BMC Womens Health</addtitle><description>Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphologic features, and PCOS is associated with infertility. PH domain Leucine-rich repeat Protein Phosphatase 1 (PHLPP1) has been shown to regulate AKT. The aim of present study is to investigate the role of PHLPP1 in PCOS.
The expression levels of PHLPP1 in dihydrotestosterone (DHT)-treated human ovarian granular KGN cells were determined by qRT-PCR and Western blot. PHLPP1 was silenced or overexpressed using lentivirus. Cell proliferation was detected by CCK-8. Apoptosis and ROS generation were analyzed by flow cytometry. Glycolysis was analyzed by measuring extracellular acidification rate (ECAR).
DHT treatment suppressed proliferation, promoted apoptosis, enhanced ROS, and inhibited glycolysis in KGN cells. PHLPP1 silencing alleviated the DHT-induced suppression of proliferation and glycolysis, and promotion of apoptosis and ROS in KGN cells. PHLPP1 regulated cell proliferation and glycolysis in human KGN cells via the AKT signaling pathway.
Our results showed that PHLPP1 mediates the proliferation and aerobic glycolysis activity of human ovarian granular cells through regulating AKT signaling.</description><subject>Acidification</subject><subject>AKT signaling</subject><subject>Analysis</subject><subject>Apoptosis</subject><subject>Care and treatment</subject><subject>Cell growth</subject><subject>Diagnosis</subject><subject>Enzymes</subject><subject>Female</subject><subject>Glucose metabolism</subject><subject>Glycolysis</subject><subject>Health aspects</subject><subject>Hormones, Sex</subject><subject>Humans</subject><subject>Infertility</subject><subject>Kinases</subject><subject>Measurement</subject><subject>Metabolism</subject><subject>Motility</subject><subject>Nuclear Proteins</subject><subject>Ovaries</subject><subject>PHLPP1</subject><subject>Phosphatases</subject><subject>Phosphoprotein Phosphatases - genetics</subject><subject>Polycystic Ovary Syndrome</subject><subject>Proteins</subject><subject>Proto-Oncogene Proteins c-akt</subject><subject>Reactive Oxygen Species</subject><subject>Sperm</subject><subject>Stein-Leventhal syndrome</subject><issn>1472-6874</issn><issn>1472-6874</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkk9vFCEYxidGY2v1C3gwJF68bIUBBuZkNo3axk3cQz2Tlz8zw2Z2WGFmm41fXqZba9cYQiDwvD_g4SmKtwRfEiKrj4mUNeYLXNLcpSgX_FlxTlieVFKw50_mZ8WrlDYYEyG5eFmcUUkk4xU5L36tr1frNUF-6Lz2Y0Jj51Abw93YIRgsAheD9ga1_cGE_pB8QmBGv_fjAYUGddMWBhT2EH0e2wjD1ENExvX9jIpharvMvi-B0Q8tWn67RTsYuzs4vC5eNNAn9-ZhvCh-fPl8e3W9WH3_enO1XC0MJ3xccFxWHIPEYAVjUktWY8DUWWo5ddpozrWFphK8Ai5rQgUua00abYxtyrqhF8XNkWsDbNQu-i3Egwrg1f1CiK2COHrTO2Vto3npsm9as7qqpJHYaE2JsIZTajPr05G1m_TWWeOGMUJ_Aj3dGXyn2rBXBAtBKsEy4cMDIYafk0uj2vo0GwaDC1NSZZ0_l1FRyyx9_490E6Y4ZK9mFSslYzX_q2ohv8APTcgHmxmqlkJkt0pZ0ay6_I8qN-u23oTBNT6vnxSUxwITQ0rRNY-PJFjN-VPH_KmcP3WfPzXf5d1Tex5L_gSO_gY6lda2</recordid><startdate>20240106</startdate><enddate>20240106</enddate><creator>Yang, Xiaoyan</creator><creator>A, Min</creator><creator>Gegen, Tana</creator><creator>Daoerji, Badema</creator><creator>Zheng, Yue</creator><creator>Wang, Aiming</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7R6</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>888</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQGEN</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>QXPDG</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20240106</creationdate><title>PHLPP1 inhibits the growth and aerobic glycolysis activity of human ovarian granular cells through inactivating AKT pathway</title><author>Yang, Xiaoyan ; A, Min ; Gegen, Tana ; Daoerji, Badema ; Zheng, Yue ; Wang, Aiming</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c515t-502650a80ad7448b8490a03ed3d53ebcb55bdaf6756a589137029b1fbccdf29f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Acidification</topic><topic>AKT signaling</topic><topic>Analysis</topic><topic>Apoptosis</topic><topic>Care and treatment</topic><topic>Cell growth</topic><topic>Diagnosis</topic><topic>Enzymes</topic><topic>Female</topic><topic>Glucose metabolism</topic><topic>Glycolysis</topic><topic>Health aspects</topic><topic>Hormones, Sex</topic><topic>Humans</topic><topic>Infertility</topic><topic>Kinases</topic><topic>Measurement</topic><topic>Metabolism</topic><topic>Motility</topic><topic>Nuclear Proteins</topic><topic>Ovaries</topic><topic>PHLPP1</topic><topic>Phosphatases</topic><topic>Phosphoprotein Phosphatases - genetics</topic><topic>Polycystic Ovary Syndrome</topic><topic>Proteins</topic><topic>Proto-Oncogene Proteins c-akt</topic><topic>Reactive Oxygen Species</topic><topic>Sperm</topic><topic>Stein-Leventhal syndrome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Xiaoyan</creatorcontrib><creatorcontrib>A, Min</creatorcontrib><creatorcontrib>Gegen, Tana</creatorcontrib><creatorcontrib>Daoerji, Badema</creatorcontrib><creatorcontrib>Zheng, Yue</creatorcontrib><creatorcontrib>Wang, Aiming</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>GenderWatch</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>GenderWatch (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest Women's & Gender Studies</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>Diversity Collection</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>BMC women's health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Xiaoyan</au><au>A, Min</au><au>Gegen, Tana</au><au>Daoerji, Badema</au><au>Zheng, Yue</au><au>Wang, Aiming</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PHLPP1 inhibits the growth and aerobic glycolysis activity of human ovarian granular cells through inactivating AKT pathway</atitle><jtitle>BMC women's health</jtitle><addtitle>BMC Womens Health</addtitle><date>2024-01-06</date><risdate>2024</risdate><volume>24</volume><issue>1</issue><spage>25</spage><epage>25</epage><pages>25-25</pages><artnum>25</artnum><issn>1472-6874</issn><eissn>1472-6874</eissn><abstract>Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphologic features, and PCOS is associated with infertility. PH domain Leucine-rich repeat Protein Phosphatase 1 (PHLPP1) has been shown to regulate AKT. The aim of present study is to investigate the role of PHLPP1 in PCOS.
The expression levels of PHLPP1 in dihydrotestosterone (DHT)-treated human ovarian granular KGN cells were determined by qRT-PCR and Western blot. PHLPP1 was silenced or overexpressed using lentivirus. Cell proliferation was detected by CCK-8. Apoptosis and ROS generation were analyzed by flow cytometry. Glycolysis was analyzed by measuring extracellular acidification rate (ECAR).
DHT treatment suppressed proliferation, promoted apoptosis, enhanced ROS, and inhibited glycolysis in KGN cells. PHLPP1 silencing alleviated the DHT-induced suppression of proliferation and glycolysis, and promotion of apoptosis and ROS in KGN cells. PHLPP1 regulated cell proliferation and glycolysis in human KGN cells via the AKT signaling pathway.
Our results showed that PHLPP1 mediates the proliferation and aerobic glycolysis activity of human ovarian granular cells through regulating AKT signaling.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>38184561</pmid><doi>10.1186/s12905-023-02872-5</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1472-6874 |
ispartof | BMC women's health, 2024-01, Vol.24 (1), p.25-25, Article 25 |
issn | 1472-6874 1472-6874 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_ddfb52e472bb49668c80cbb317dc533d |
source | PubMed Central (Open Access); Publicly Available Content Database |
subjects | Acidification AKT signaling Analysis Apoptosis Care and treatment Cell growth Diagnosis Enzymes Female Glucose metabolism Glycolysis Health aspects Hormones, Sex Humans Infertility Kinases Measurement Metabolism Motility Nuclear Proteins Ovaries PHLPP1 Phosphatases Phosphoprotein Phosphatases - genetics Polycystic Ovary Syndrome Proteins Proto-Oncogene Proteins c-akt Reactive Oxygen Species Sperm Stein-Leventhal syndrome |
title | PHLPP1 inhibits the growth and aerobic glycolysis activity of human ovarian granular cells through inactivating AKT pathway |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T02%3A47%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PHLPP1%20inhibits%20the%20growth%20and%20aerobic%20glycolysis%20activity%20of%20human%20ovarian%20granular%20cells%20through%20inactivating%20AKT%20pathway&rft.jtitle=BMC%20women's%20health&rft.au=Yang,%20Xiaoyan&rft.date=2024-01-06&rft.volume=24&rft.issue=1&rft.spage=25&rft.epage=25&rft.pages=25-25&rft.artnum=25&rft.issn=1472-6874&rft.eissn=1472-6874&rft_id=info:doi/10.1186/s12905-023-02872-5&rft_dat=%3Cgale_doaj_%3EA778492863%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c515t-502650a80ad7448b8490a03ed3d53ebcb55bdaf6756a589137029b1fbccdf29f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2914284495&rft_id=info:pmid/38184561&rft_galeid=A778492863&rfr_iscdi=true |